Related Experiment Video

Updated: Dec 20, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K

COVID-19 and Multiorgan Response

Sevim Zaim, Jun Heng Chong, Vissagan Sankaranarayanan

    Current Problems in Cardiology
    |May 23, 2020
    PubMed

    Insights

    COVID-19 severity and mortality are significantly impacted by multiorgan involvement and pre-existing conditions. Understanding these effects is crucial for effective patient management and treatment strategies.

    Area of Science:

    • Infectious Diseases
    • Cardiology
    • Nephrology
    • Hepatology
    • Critical Care Medicine

    Background:

    • The COVID-19 pandemic, caused by SARS-CoV-2, has demonstrated a significant impact on patient prognosis due to multiorgan involvement.
    • Comorbidities, particularly cardiovascular diseases, are strongly associated with increased severity and mortality in COVID-19 patients.
    • The hyperinflammatory response and direct viral effects via ACE2 contribute to widespread organ damage.

    Purpose of the Study:

    • To synthesize current knowledge on the multiorgan impact of COVID-19.
    • To highlight the role of comorbidities in COVID-19 prognosis.
    • To emphasize the importance of recognizing and managing organ injuries in COVID-19 patients.

    Main Methods:

    • Review of existing literature on COVID-19 pathophysiology and clinical manifestations.
    • Analysis of reported cases detailing multiorgan complications.
    • Synthesis of data on the association between comorbidities and COVID-19 outcomes.

    Main Results:

    • COVID-19 frequently leads to acute respiratory distress syndrome, heart failure, renal failure, liver damage, and shock.
    • Multiorgan failure is a common pathway to mortality in severe COVID-19 cases.
    • Pre-existing cardiovascular conditions exacerbate COVID-19 severity and increase mortality risk.

    Conclusions:

    • Clinical management of COVID-19 requires careful consideration of patient comorbidities.
    • Prompt recognition and management of organ-specific injuries are essential for improving outcomes.
    • Further research into the mechanisms of COVID-19-induced organ damage is warranted.

    More Related Videos

    Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses09:43

    Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

    Published on: March 8, 2024

    2.3K
    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture10:05

    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

    Published on: April 28, 2015

    29.5K

    Related Concept Videos

    Immune Response Against Viral Pathogens01:29

    Immune Response Against Viral Pathogens

    The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
    NK Cells
    NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
    1.5K
    Tissue Transplantation01:24

    Tissue Transplantation

    Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
    The Biology of Tissue Transplantation
    The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
    794
    Inflammatory Response01:28

    Inflammatory Response

    An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
    Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
    15.6K
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    2.3K
    Acute Respiratory Failure-III01:30

    Acute Respiratory Failure-III

    Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
    655
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    902